Clinical efficacy and safety of nuanxin capsule for chronic heart failure: A systematic review and meta-analysis.

ABSTRACT:

Background

Chronic heart failure (CHF), the final phase of various heart diseases, is a serious public health problem resulting in high hospitalization rates, mortality, and increasing health care costs. Nuanxin capsule (NXC), a Chinese herbal formula, has been widely used in the treatment of CHF. However, the safety and efficacy of NXC used in patients with CHF has been uncertain and there has been no standard clinical trial published to confirm this. Thus, we conduct a study to evaluate the safety and efficacy of NXC for CHF.

Methods

The reference lists of randomized controlled trials and 8 electronic databases will be independently and systematically searched by 2 review authors in May 2018. Four English databases (EMBASE, PubMed, Cumulative Index to Nursing and Allied He

SUBMITTER: Li Z 

PROVIDER: S-EPMC6076094 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature